Adjuvant lapatinib for women with early-stage HER2-positive breast cancer: A randomised, controlled, phase 3 trial

  1. Goss, P.E.
  2. Smith, I.E.
  3. O'Shaughnessy, J.
  4. Ejlertsen, B.
  5. Kaufmann, M.
  6. Boyle, F.
  7. Buzdar, A.U.
  8. Fumoleau, P.
  9. Gradishar, W.
  10. Martin, M.
  11. Moy, B.
  12. Piccart-Gebhart, M.
  13. Pritchard, K.I.
  14. Lindquist, D.
  15. Chavarri-Guerra, Y.
  16. Aktan, G.
  17. Rappold, E.
  18. Williams, L.S.
  19. Finkelstein, D.M.
Revue:
The Lancet Oncology

ISSN: 1470-2045 1474-5488

Année de publication: 2013

Volumen: 14

Número: 1

Pages: 88-96

Type: Article

DOI: 10.1016/S1470-2045(12)70508-9 GOOGLE SCHOLAR